Public Health Agency of Canada

Positive mental health is the capacity of people to feel, think, and act in ways that enhance the ability to enjoy life and deal with challenges.

Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice(the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada.The journal publishes articles on disease...

National Laboratory Surveillance of Invasive Streptococcal Disease in Canada - Annual Executive Summary 2015

To support its commitment to increasing vaccination coverage in Canada, the Government of Canada launched the Immunization Partnership Fund (IPF). This fund provides $2 to $3 million per year for projects aimed at improving vaccination coverage in Canada.

The Plan for Administrative Oversight submissions are intended to be high level and provide an overview of the mechanisms that are in place in an institution or organization to administratively manage and control biosafety and biosecurity risks.

PHAC developed this Regulatory Openness and Transparency Framework (ROTF) with a view to contribute to the protection and promotion of the health of Canadians and their confidence in the regulatory system through timely and open communications on issues important to their well-being. The ROTF is...

This evaluation covered the period from April 1, 2009 to August 31, 2014 and included all the activities undertaken by the Travel and Migration Health Division (TMHD) and those undertaken by the Office of Border Health Services (OBHS). The evaluation was undertaken in fulfillment of the Treasury...

This report tells the story of how the Centre took action to ensure a successful transition to the new regulatory regime by managing change, promoting compliance among regulated parties, and influencing global biosafety and biosecurity regulatory efforts leading up to and throughout the ensuing...

This biosafety directive is intended to provide a comprehensive overview of the risk assessment outcomes, subsequent containment level decisions, and considerations that have been made for those working with MTBC. It describes the activities and MTBC sample types that can be handled at CL2 with...

Health Promotion and Chronic Disease Prevention in Canada: Research, Policy and Practice(the HPCDP Journal) is the monthly, online scientific journal of the Health Promotion and Chronic Disease Prevention Branch of the Public Health Agency of Canada.The journal publishes articles on disease...

The Canada Communicable Disease Report is a bilingual, open-access, peer-reviewed journal on the prevention and control of emerging and persistent infectious diseases. 

This guideline describes the general recommendations and considerations for basic laboratory design and the safe handling of RG1 biological material; these recommended practices are risk-and evidence-based. The physical design features and operational practices for CL1 zones described in this...

"The Canadian Biosafety Guidelines have been developed by the Public Health Agency of Canada (PHAC) and the Canadian Food Inspection Agency (CFIA) as an ongoing series of biosafety and biosecurity themed guidance documents. In Canada, most facilities where human and terrestrial animal pathogens...

In Canada, facilities where Risk Group 2, 3, and 4 human pathogens or toxins are handled and stored are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal...

In Canada, facilities where Risk Group 2, 3, and 4 human pathogens or toxins are handled and stored are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal...

"In Canada, facilities that handle or store Risk Group 2 (RG2), RG3, and RG4 human pathogens or toxins are regulated by the Public Health Agency of Canada (PHAC) under the Human Pathogens and Toxins Act (HPTA) and the Human Pathogens and Toxins Regulations (HPTR). The importation of animal...

The biosafety handbook on safe and secure handling of pathogens and toxins in Canada.

This Guideline provides comprehensive guidance on how to complete and submit a notification report and, where exposure or laboratory acquired infections/intoxications (LAIs) is concerned, a subsequent follow-up report to the Public Health Agency of Canada in accordance with requirements in the...

The Local Risk Assessment guideline describes best practices for conducting a local risk assessment (LRA) in an organization where human or animal pathogens, toxins, or other regulated infectious material are handled or stored.

The human immunodeficiency virus (HIV) and the human T-cell lymphotropic virus type 1 (HTLV-1) are examples of RG3 pathogens where the pathogen risk and CL assessments have been revisited by the Agency in conjunction with HIV/HTLV specialists based on current risks associated with activities...